Heart Disease Journals

Cardiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Roffi M et al. – The analysis showed that CAS was associated with a statistically significant increased death or stroke rate at 30 days compared with CEA. However, most of the trials had inadequate requirements in terms of endovascular expertise and did not mandate the use of emboli protection devices. Beyond 30 days, long–term follow–up of the trials previously reported suggest that both revascularization techniques are equivalent in terms of stroke prevention.


Today in Atherosclerosis/Lipids...keeping you current

Nutritional supplements and serum lipids: Does anything work
Current Atherosclerosis Reports, 11/16/09

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09

Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy , 11/16/09

Today in Interventional...keeping you current

Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09

Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrillation
American Family Physician, 11/12/09

Adverse event rates in congenital cardiac catheterization- A multi-center experience
Catheterization and Cardiovascular Interventions, 11/06/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address